In a xenograft MBA-MB-435 model of breast cancer, subcutaneous injections of NAC at 10 mg/kg body weight daily decreased tumor growth by promoting the production of anti-angiogenic factors such as angiostatin, resulting in vascular collapse and extensive necrosis within the tumor [36]. The gene discussed is PLG; the disease is breast cancer.